Schneider Jens P, Trantakis Christos, Rubach Matthias, Schulz Thomas, Dietrich Juergen, Winkler Dirk, Renner Christof, Schober Ralf, Geiger Kathrin, Brosteanu Oana, Zimmer Claus, Kahn Thomas
Diagnostic Radiology, University of Leipzig, Germany.
Neuroradiology. 2005 Jul;47(7):489-500. doi: 10.1007/s00234-005-1397-1. Epub 2005 Jun 11.
Patients with supratentorial high-grade glioma underwent surgery within a vertically open 0.5-T magnetic resonance (MR) system to evaluate the efficacy of intraoperative MR guidance in achieving gross-total resection. For 31 patients, preoperative clinical data and MR findings were consistent with the putative diagnosis of a high-grade glioma, in 23 cases in eloquent regions. Tumor resections were carried out within a 0.5-T MR SIGNA SP/i (GE Medical Systems, USA). The resection of the lesion was carried out using fully MR compatible neurosurgical equipment and was stopped at the point when the operation was considered complete by the surgeon viewing the operation field with the microscope. We repeated imaging to determine the residual tumor volume only visible with MRI. Areas of tissue that were abnormal on these images were localized in the bed of resection by using interactive MR guidance. The procedure of resection, imaging control and interactive image guidance was repeated where necessary. Almost all tissue with abnormal characteristics was resected, with the exception of tissue localized in eloquent brain areas. The diagnosis of glioblastoma was confirmed in all 31 cases. When comparing the tumor volume before resection and at the point where the neurosurgeon would otherwise have terminated surgery ("first control"), residual tumor tissue was detectable in 29/31 patients; the mean residual tumor volume was 30.7 +/- 24%. After repeated resections under interactive image guidance the mean residual tumor volume was 15.1%. At this step we found tumor remnants only in 20/31 patients. The perioperative morbidity (12.9%) was low. Twenty-seven patients underwent sufficient postoperative radiotherapy. We found a significant difference (log(rank)p = 0.0037) in the mean survival times of the two groups with complete resection (n = 10, median survival time 537 days) and incomplete resection (n = 17, median survival time 237 days). The resection of primary glioblastoma multiforme under intraoperative MR guidance as demonstrated is a possibility to achieve a more complete removal of the tumor than with conventional techniques. In our small but homogeneous patient group we found an increase in the median survival time in patients with MRI for complete tumor resection, and the overall surgical morbidity was low.
幕上高级别胶质瘤患者在垂直开放的0.5-T磁共振(MR)系统中接受手术,以评估术中MR引导在实现肿瘤全切除方面的疗效。31例患者术前临床资料和MR表现与高级别胶质瘤的推测诊断一致,其中23例位于功能区。肿瘤切除在0.5-T MR SIGNA SP/i(美国通用电气医疗系统公司)中进行。使用完全兼容MR的神经外科设备进行病变切除,当外科医生通过显微镜观察术野认为手术完成时停止操作。我们重复成像以确定仅在MRI上可见的残余肿瘤体积。通过交互式MR引导,将这些图像上异常的组织区域定位在切除床内。必要时重复切除、成像控制和交互式图像引导过程。几乎所有具有异常特征的组织均被切除,但位于功能区脑区的组织除外。所有31例均确诊为胶质母细胞瘤。比较切除前与神经外科医生否则会终止手术的点(“首次对照”)时的肿瘤体积,29/31例患者可检测到残余肿瘤组织;平均残余肿瘤体积为30.7±24%。在交互式图像引导下重复切除后,平均残余肿瘤体积为15.1%。在此阶段,我们仅在20/31例患者中发现肿瘤残余。围手术期发病率较低(12.9%)。27例患者接受了充分的术后放疗。我们发现完全切除组(n = 10,中位生存时间537天)和不完全切除组(n = 17,中位生存时间237天)的平均生存时间存在显著差异(对数秩检验p = 0.0037)。如所示,在术中MR引导下切除原发性多形性胶质母细胞瘤有可能比传统技术更完整地切除肿瘤。在我们这个小而同质的患者组中,我们发现通过MRI实现肿瘤完全切除的患者中位生存时间增加,且总体手术发病率较低。